Product Information |
|
Registration Number |
DR-XY33139
|
Generic Name |
Zoledronic Acid
|
Brand Name |
Aclasta
|
Dosage Strength |
5 mg/100 mL
|
Dosage Form |
Solution for Intravenous Infusion
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
Biphosphonate
|
Packaging |
Colorless plastic vial with rubber and aluminum cap with flip-off component
|
Manufacturer |
Novartis Pharma Stein AG
|
Country of Origin |
Switzerland
|
Trader |
|
Importer |
Novartis Healthcare Phils., Inc.
|
Distributor |
|
Application Type |
Renewal
|
Issuance Date |
23 February 2022
|
Expiry Date |
27 March 2027
|